Title:
【発明の名称】タクサン化合物およびテルルおよび/またはセレン化合物の併用により腫瘍の発育を減少させるための方法および組成物
Document Type and Number:
Japanese Patent JPH10510812
Kind Code:
A
Abstract:
There are provided compositions for, and a method of, treating malignancies which comprise effective amounts of a novel combined therapy comprising a taxane compound, e.g., paclitaxel, and a tellurium or selenium compound, e.g., ammonium trichloro(dioxoethylene-O,O-tellurate), and administering the respective compounds simultaneously or separately.
Inventors:
Threadney, Benjamin
Bruckner, Howard Bee
Arbect, Michael
John Wisnanth
Mettinger, Karl El
Bruckner, Howard Bee
Arbect, Michael
John Wisnanth
Mettinger, Karl El
Application Number:
JP51921496A
Publication Date:
October 20, 1998
Filing Date:
December 12, 1995
Export Citation:
Assignee:
Baker Norton Pharmaceuticals, Inc.
International Classes:
A61K31/335; A61K31/555; A61P35/00; A61P43/00; (IPC1-7): A61K31/335; A61K31/335
Attorney, Agent or Firm:
Toru Sakamoto (1 person outside)
Previous Patent: 白金およびテルルまたはセレン化合物の併用により腫瘍の発育を減少させ...
Next Patent: 治療分子の細胞内送達のためのカチオン性両親媒性化合物およびプラスミ...
Next Patent: 治療分子の細胞内送達のためのカチオン性両親媒性化合物およびプラスミ...